Larimar Therapeutics, Inc. Board of Directors

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.

Dr. Carole S. Ben-Maimon M.D.

Dr. Carole S. Ben-Maimon M.D.

CEO, President & Director

Ms. Jennifer Spokes Johansson

Ms. Jennifer Spokes Johansson

Vice President of Legal & Compliance

Mr. John Berman

Mr. John Berman

Vice President of Finance & Administration

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.